Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viemed Healthcare (VMD) Total Current Liabilities (2018 - 2025)

Viemed Healthcare's Total Current Liabilities history spans 8 years, with the latest figure at $41.1 million for Q4 2025.

  • For Q4 2025, Total Current Liabilities rose 9.99% year-over-year to $41.1 million; the TTM value through Dec 2025 reached $41.1 million, up 9.99%, while the annual FY2025 figure was $41.1 million, 9.99% up from the prior year.
  • Total Current Liabilities reached $41.1 million in Q4 2025 per VMD's latest filing, down from $44.2 million in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $44.2 million in Q3 2025 to a low of $17.7 million in Q1 2022.
  • Average Total Current Liabilities over 5 years is $28.3 million, with a median of $30.8 million recorded in 2024.
  • Peak YoY movement for Total Current Liabilities: crashed 42.34% in 2021, then soared 76.8% in 2023.
  • A 5-year view of Total Current Liabilities shows it stood at $17.8 million in 2021, then grew by 5.9% to $18.9 million in 2022, then soared by 70.32% to $32.1 million in 2023, then grew by 16.19% to $37.3 million in 2024, then grew by 9.99% to $41.1 million in 2025.
  • Per Business Quant, the three most recent readings for VMD's Total Current Liabilities are $41.1 million (Q4 2025), $44.2 million (Q3 2025), and $37.3 million (Q2 2025).